has served on advisory boards to Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk and Roche, and received travel support from Eli Lilly and Company and Boehringer Ingelheim, honorarium and travel support from Roman Health Ventures Inc., and received grant support, on behalf of Johns Hopkins University, from Eli Lilly and Company
Jagim AR, Harty PS, Barakat AR, et al
Polysaccharides-based nanoparticles as drug delivery systems
Long noncoding rna uca1 promotes glutamine-driven anaplerosis of bladder cancer by interacting with hnrnp I/L to upregulate gpt2 expression
Separate vials allow researchers to start retatrutide first, build tolerance, then layer in cagrilintide, which helps isolate which compound causes a given side effect